Literature DB >> 4044100

Thymosin alpha 1 exerts protective effect against the 5-FU induced bone marrow toxicity.

Y Ohta, E Tezuka, S Tamura, Y Yagi.   

Abstract

Thymosin alpha 1 was shown to prevent the 5-fluorouracil(5-FU)-induced bone marrow toxicity in BDF1 mice, as determined by the cellularity, haemopoietic stem cells (CFU-s) and granulocyte-macrophage colony forming unit (GM-CFU). Furthermore, thymosin alpha 1 increased the levels of colony stimulating factor (CSF) in sera or in culture media of spleen cells derived from 5-FU-treated mice. The treatment of spleen cells with anti-Thy 1,2 antibody plus complement abolished completely the CSF production. The in vivo treatment of donor mice with anti-Thy 1,2 antibody following 5-FU abolished completely the capability of their bone marrow cells to save lethally irradiated recipients. Thymosin alpha 1 treatment prevented the damage by such combined treatment. The present study indicates that thymosin alpha 1 exerts its protective effect against the 5-FU-induced bone marrow toxicity, at least partially, through its effect on the maturation of immature T cells to functional T cells which produce various kinds of lymphokines including CSF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044100     DOI: 10.1016/0192-0561(85)90163-8

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  5 in total

1.  Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.

Authors:  Deliang Cao; Amy Ziemba; James McCabe; Ruilan Yan; Laxiang Wan; Bradford Kim; Michael Gach; Stuart Flynn; Giuseppe Pizzorno
Journal:  Mol Cancer Ther       Date:  2011-09-27       Impact factor: 6.261

Review 2.  Thymic hormones--a clinical update.

Authors:  M B Sztein; A L Goldstein
Journal:  Springer Semin Immunopathol       Date:  1986

Review 3.  Thymosins and anti-thymosins: properties and clinical applications.

Authors:  A L Goldstein; R S Schulof; P H Naylor; N R Hall
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

4.  A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Robert G Gish; Stuart C Gordon; David Nelson; Vinod Rustgi; Israel Rios
Journal:  Hepatol Int       Date:  2009-05-08       Impact factor: 6.047

5.  Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.

Authors:  Walter Mandaliti; Ridvan Nepravishta; Francesca Pica; Paola Sinibaldi Vallebona; Enrico Garaci; Maurizio Paci
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.